Bharat Gummadi, MD
Interventional Cardiology · Jacksonville, FLNPI 1033141692
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $95,012 of the $152,500 with a category attached, or 62.3%. 60 manufacturers reported payments, led by Amgen at 53.7% of the total. Among interventional cardiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 953 payments — averaging $160.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$82K
- Shockwave Medical, Inc$29K
- Abbott$7K
- Abiomed$6K
- Penumbra, Inc.$6K
- Inari Medical, Inc.$5K
- plus $17K from 54 others
Across 341 payments — averaging $546.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$99K
- Medtronic$87K
What the payments were for
- Consulting fees$6,6004%
- Speaking & faculty fees$95,01262%
- Travel & lodging$15,07510%
- Food & beverage$35,78923%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$80,839
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$20,271
- Vascular Lithotripsy$6,969
- Indigo System$4,770
- FLOWTRIEVER CATHETER, S$4,652
- CT THROMBECTOMY SYSTEM KIT$4,652
- Impella$4,016
- OPTIS$2,006
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,884
- Abre$955
- MitraClip$724
- Emboshield NAV6 system$721
- Omnilink Elite vascular stent system$715
- SAPIEN 3 Ultra RESILIA$627
- Telescope$459
- LIMFLOW SYSTEM$296
- Barostim Neo System$265
- Torus Stent Graft System$260
- ENDOCROSS Device$260
- (6574) Coronary Other$257
How this compares
$152,500 in reported general payments places this provider in the 95th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 153 | $150,521 |
| Repatha SureclickEvolocumab | 72 | $72,645 |
| EntrestoSacubitril/Valsartan | 49 | $61,732 |
| BrilintaTicagrelor | 99 | $46,897 |
| Repatha PushtronexEvolocumab | 36 | $26,019 |
| XareltoRivaroxaban | 20 | $24,920 |
| Repatha SyringeEvolocumab | 11 | $12,464 |
| Ranolazine ErRanolazine | 82 | $8,655 |
| Metoprolol Succinate | 289 | $3,767 |
| ClopidogrelClopidogrel Bisulfate | 340 | $3,219 |
| Prasugrel Hcl | 33 | $2,080 |
| Atorvastatin Calcium | 180 | $1,845 |
| Rosuvastatin Calcium | 142 | $1,390 |
| Amlodipine Besylate | 87 | $780 |
| Ezetimibe | 52 | $747 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $203 | $150,521153 claims |
| NovartisEntresto | $229 | $61,73249 claims |
| AstraZenecaBrilinta | $462 | $46,89799 claims |
| Johnson & JohnsonXarelto | $650 | $24,92020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Jacksonville
- Siddharth WayangankarJacksonville$1.2M
- Dominick AngiolilloJacksonville$387K
- Ruby SatpathyJacksonville$205K
- Raguveer MurthyJacksonville$65K
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.